{"page_content": "2020 CORPORATE SOCIAL RESPONSIBILITY REPORT70\nDear Communities\nABOUT SERVE TRANSFORM ADVANCE REDEFINE ETHICS & COMPLIANCE REPORTING INDEX   \nTamar Thompson,\nVice President Government Affairs and \nPolicy, Alexion Pharmaceuticals, Inc. and \nChairperson, Alexion Charitable FoundationGOVERNING OUR POLITICAL\nACTIVITIES  \nAs head of Government Affairs and Policy,  \n I have the privilege of serving rare disease \npatients by working to mitigate access hurdles \nand address the challenges of health equity \nby collaborating with alliance development \npartners to shape a better healthcare system \nfor the rare disease community. This role \nprovides an opportunity to draw upon the \ndiversity of my experience as a military wife, \nsister, daughter and health policy strategist to \nadvance healthcare legislative and regulatory \npriorities for rare disease.\nOur actions are guided by our Policy on Political  \nContributions and Lobbying Activity . Our  \nstrong and successful policies and practices \nhave resulted in Alexion being ranked in the \ntop tier on the 2020 CPA-Zicklin Index, which \nevaluates S&P 500 companies on their  \npolitical spending disclosure practices  \nand oversight policies.Now more than ever, it is imperative that \nAlexion works to ensure that we align our global \ngovernment affairs positions and principles, not \nonly with the enterprise business needs, but \nalso with our organizational values. Among the \nways we\u2019re acting on this ambition is to advance \na patient-centered ecosystem that aligns with \nthe expectations of a broad array of external stakeholders. Alexion seeks to continuously listen \nto patients and other stakeholders and to build \ninnovative partnerships and community that lead \nto systemwide improvements for the rare disease \ncommunity.\nThis year, the U.S. and International Government \nAffairs and Policy teams launched the Alexion \nHealth Policy Council to govern the alignment \nof our policy positions. The Health Policy Council \nserves as a venue for cross matrix teams to \naddress and respond to emerging policy trends \nby developing organizational principles and \n\u201c\u201dThis is an exciting\nand important time \nfor the rare disease \ncommunity.\nPatients Provider Policymakers Payers ExpertsMarket \nPartners PATIENT-CENTERED ECOSYSTEM", "metadata": {"source": "NASDAQ_ALXN_2020.pdf", "page": 69, "parser": "pypdf", "split_method": "page", "run_time": "2024-05-29 08:35:04"}, "type": "Document"}